Search Results for "SOLARIS"
Found 1 result for "SOLARIS"
FDA Approves Weltruza: First Once-Monthly Subcutaneous Olanzapine for Schizophrenia
The FDA has approved Weltruza, a once-monthly subcutaneous formulation of olanzapine for schizophrenia. The approval is based on the phase 3 SOLARIS trial and offers a simplified regimen with no loadi…